Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Vaccine-associated enhanced disease and pathogenic human coronaviruses

[thumbnail of Publisher's version]
Preview
PDF (Publisher's version) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB

Item Type:Review
Title:Vaccine-associated enhanced disease and pathogenic human coronaviruses
Creators Name:Gartlan, C., Tipton, T., Salguero, F.J., Sattentau, Q., Gorringe, A. and Carroll, M.W.
Abstract:Vaccine-associated enhanced disease (VAED) is a difficult phenomenon to define and can be confused with vaccine failure. Using studies on respiratory syncytial virus (RSV) vaccination and dengue virus infection, we highlight known and theoretical mechanisms of VAED, including antibody-dependent enhancement (ADE), antibody-enhanced disease (AED) and Th2-mediated pathology. We also critically review the literature surrounding this phenomenon in pathogenic human coronaviruses, including MERS-CoV, SARS-CoV-1 and SARS-CoV-2. Poor quality histopathological data and a lack of consistency in defining severe pathology and VAED in preclinical studies of MERS-CoV and SARS-CoV-1 vaccines in particular make it difficult to interrogate potential cases of VAED. Fortuitously, there have been only few reports of mild VAED in SARS-CoV-2 vaccination in preclinical models and no observations in their clinical use. We describe the problem areas and discuss methods to improve the characterisation of VAED in the future.
Keywords:Vaccine-Associated Enhanced Disease, COVID-19, SARS-CoV-2, Coronavirus, Vaccine, Enhancement, Safety
Source:Frontiers in Immunology
ISSN:1664-3224
Publisher:Frontiers Media SA
Volume:13
Page Range:882972
Date:4 April 2022
Official Publication:https://doi.org/10.3389/fimmu.2022.882972
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library